What you are saying is inconsistent with the information we have been supplied. SI clearly stated that readouts 1 & 2 had the treated arm tracking better than placebo. He also discussed the changes that have occurred including delays in ventilation with other treatments being applied in preference to ventilation. This change has been widely reported in the media since around June. I prefer using the information that is available in preference to your jaundiced and frankly libellous claims.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-650
-
- There are more pages in this discussion • 426 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |